XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Net product sales $ 31,434 $ 26,557 $ 92,811 $ 77,644
Cost of product sales 18,208 14,717 55,220 42,247
Gross profit 13,226 11,840 37,591 35,397
Operating expenses:        
Research and development 13,558 25,545 44,947 96,449
General and administrative 11,641 9,799 37,724 28,513
Sales and marketing 12,956 18,378 55,315 64,738
Total operating expenses 38,155 53,722 137,986 189,700
Loss from operations (24,929) (41,882) (100,395) (154,303)
Other income (expense), net (79) (26) 560 (7,852)
Net loss (25,008) (41,908) (99,835) (162,155)
Other comprehensive income (loss):        
Unrealized gains (losses) on short-term investments 5 (46) 18 (51)
Comprehensive loss $ (25,003) $ (41,954) $ (99,817) $ (162,206)
Basic net loss per share $ (0.17) $ (0.38) $ (0.75) $ (1.54)
Weighted average common shares outstanding, basic 144,990 111,735 133,747 105,456
Diluted net loss per share $ (0.17) $ (0.38) $ (0.75) $ (1.54)
Weighted average common shares outstanding, diluted 144,990 111,735 133,747 105,456